骨髓增生性疾病

它曾被报告与淋巴母细胞转变相关的急性骨髓性白血病、骨髓增生性疾病、脊髓发育不全症等等，甚至于那些不具已知的血液学异常相关的病人们身上。

It has been reported in association with acute myeloid leukemia , myeloproliferative disorders , and myelodysplasia in blast transformation , as well as in patients with no known hematological disorders .

目的探讨骨髓增生性疾病（MPD）与降钙素（CT）基因高度甲基化的关系。

Objective To explore the relationship between myeloproliferative disorders ( MPD ) and calcitonin ( CT ) gene hypermethylation .

骨髓增生性疾病止血功能的研究

Hematostatic Function in Myeloproliferative Diseases

结论髓系肉瘤可孤立出现或发生于各种骨髓增生性疾病的病程中或经治疗缓解后。

Conclusions Myeloid sarcoma may precede , develop in a background of myeloproliferative disorder or even after remission of the disease .

结果：在正常人及骨髓良性增生性疾病患者的骨髓细胞中未见EGFR表达，在恶性血液病患者的骨髓细胞中也未见EGFR表达。

Results : The bone marrow cells from healthy controls and patients with benign hematologic diseases had no EGFR expression and so did the bone marrow cells from malignant hematologic diseases .